Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Use of pretreatment prostate specific antigen doubling time to predict outcome after radical prostatectomy.

Egawa S, Arai Y, Tobisu K, Kuwao S, Kamoto T, Kakehi Y, Baba S.

Prostate Cancer Prostatic Dis. 2000 Dec;3(S1):S11. No abstract available.

2.

[Prostate cancer recurrence after radical prostatectomy and salvage radiotherapy].

Ojea Calvo A, Pérez Rodríguez A, Domínguez Freire F, Alonso Rodrigo A, Rodríguez Iglesias B, Benavente Delgado J, Barros Rodríguez JM, González Piñeiro A, Otero García M, Muñoz Garzón V.

Actas Urol Esp. 2004 Nov-Dec;28(10):743-8. Review. Spanish.

PMID:
15666516
3.

Prostate specific antigen recurrence after definitive therapy.

Freedland SJ, Moul JW.

J Urol. 2007 Jun;177(6):1985-91. Review.

PMID:
17509277
5.

The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy.

Stephenson AJ, Slawin KM.

Nat Clin Pract Urol. 2004 Dec;1(2):90-6. Review.

PMID:
16474521
6.
7.

Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

Simmons MN, Stephenson AJ, Klein EA.

Eur Urol. 2007 May;51(5):1175-84. Review.

PMID:
17240528
Items per page

Supplemental Content

Support Center